Publication & Citation Trends
Publications
0 total
Axes of biological variation in diffuse large B cell lymphoma.
Cited by 2
Semantic Scholar
A phase 1 trial of romidepsin, azacitidine, dexamethasone, and lenalidomide in relapsed or refractory T-cell lymphoma OA
Cited by 1
Semantic Scholar
Pathogenesis of diffuse large B cell lymphoma proteogenotypes. OA
Cited by 0
Semantic Scholar
Molecular Pathogenesis and Therapeutic Response of Diffuse Large B Cell Lymphoma Genetic Subtypes OA
Cited by 0
Semantic Scholar
RHOA controls oncogenic B cell receptor signaling in aggressive lymphoma OA
Cited by 0
Semantic Scholar
The anti‐CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B‐cell lymphomas
Cited by 5
Semantic Scholar
Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma–GATA3 molecular subgroup
Cited by 1
Semantic Scholar
POSTER: IBCL-1106 Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma: A Phase 2 Study
Cited by 0
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(450)
Chronic Lymphocytic Leukemia Research
(202)
CAR-T cell therapy research
(125)
Monoclonal and Polyclonal Antibodies Research
(102)
Immune Cell Function and Interaction
(76)
Affiliations
The Wistar Institute
Human Genome Sciences (United States)
Ontario Institute for Cancer Research
University of North Carolina at Chapel Hill
University of Southern California
External Profiles
Continue on JournalsHub
Put what you just read into practice with these free tools.